Neurological critical care

Current Opinion in Pediatrics

Volumn 12, Issue 3, 2000, Pages 222-226

  Tasker, Robert C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; MIDAZOLAM;

ANTICONVULSANT THERAPY; ARTICLE; BRAIN EDEMA; COMA; EPILEPTIC STATE; HEAD INJURY; HYPERVENTILATION; INTENSIVE CARE; PRIORITY JOURNAL; SEIZURE; TREATMENT PLANNING;

BRAIN DISEASES; BRAIN INJURIES; CHILD; COMA; CRITICAL CARE; HUMANS; STATUS EPILEPTICUS;

EID: 0034127136     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200006000-00008     Document Type: Article

References (50)

1. 1 Biagas K: Hypoxic-ischemic brain injury: advancement in the understanding of mechanisms and potential avenues for therapy. Curr Opin Pediatr 1999, 11:223-228. This is a useful overview of potential therapies and pathophysiology.
2. 2 Tasker RC: Pharmacological advance in the treatment of acute brain injury. Arch Dis Child 1999, 81:90-95. This review and framework is useful for evaluating the clinical translation of experimental literature.
3. 3 Brain Trauma Foundation, American Association of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care: Guidelines for the management of severe head injury. J Neurotrauma 1996, 13:641-734.
4. 4 Ghajar J, Hariri RJ, Narayan RK, Iacono LA, Firlik K, Patterson RH: Survey of critical care management of comatose, head-injured patients in the United States. Crit Care Med 1995, 23:560-567.
5. 5 Jeevaratnam DR, Menon DK: Survey of intensive care of severely head injured patients in the United Kingdom. BMJ 1996, 312:944-947.
6. 6 Matta B, Menon D: Severe head injury in the United Kingdom and Ireland: a survey of practice and implications for management. Crit Care Med 1996, 24:1743-1748.
7. 7 Schierhout G, Roberts I: The Cochrane brain and spinal cord injury group. J Neurol Neurosurg Psychiatry 1997, 63:1-3.
8. 8 The Cochrane Library: Database on disk and CD ROM. Oxford: Cochrane Collaboration, Update Software; 1999. Updated quarterly.
9. 9 Zwienenberg M, Muizelaar JP: Severe pediatric head injury: the role of hyperemia revisited. J Neurotrauma 1999, 16:937-943. This review of hyperemia in severe pediatric head injury is comprehensive in its discussion and debate and is appropriately questioning in its evaluation of some widely held assumptions.
10. 10 Sharpies PM, Stuart AG, Matthews DS, Aynsley-Green A, Eyre JA: Cerebral blood flow and metabolism in children with severe head injury. Part 1: Relation to age, Glasgow coma score, outcome, intracranial pressure, and time after injury. J Neurol Neurosurg Psychiatry 1995, 58:145-152.
11. 11 Skippen P, Seear M, Poskitt K, Kestle J, Cochrane D, Annich G, et al.: Effect of hyperventilation on regional cerebral blood flow in head-injured children. Crit Care Med 1997, 25:1402-1409.
12. 12 Bruce DA, Alavi A, Bilaniuk L, Dolinskas C, Obrist W, Uzzell B: Diffuse cerebral swelling following head injuries in children: the syndrome of "malignant brain edema". J Neurosurg 1981, 54:170-178.
13. 13 Lang DA, Teasdale GM, Macpherson P, Lawrence A: Diffuse brain swelling after head injury: more often malignant in adults than children? J Neurosurg 1994, 80:675-680.
14. 14 Aldrich EF, Eisenberg HM, Saydjari C, Luerssen TG, Foulkes MA, Jane JA, et al.: Diffuse brain swelling in severely head-injured children. A report from the NIH Traumatic Coma Data Bank. J Neurosurg 1992, 76:450-454.
15. 15 Geraci E, Geraci T: A look at recent hyperventilation studies: outcomes and recommendations for early use in the head-injured patient. J Neurosci Nurs 1996, 28:222-224, 229-233.
16. 16 Lewis SB, Myburgh JA, Reilly PL: Detection of cerebral venous desaturation by continuous jugular bulb oximetry following acute neurotrauma. Anaesth Intensive Care 1995, 23:307-314.
17. 17 Muizelaar JP, Marmarou A, Ward JD, Kontos HA, Choi SC, Becker DP, et al.: Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg 1991, 75:731-739.
18. 18 Schierhout G, Roberts I: Hyperventilation therapy for acute traumatic brain injury (Cochrane Review) [computer program]. In: The Cochrane Library, Issue 4. Oxford, UK: Update Software; 1999. This is a detailed assessment of the 113 participants in the single randomized controlled trial of hyperventilation for traumatic brain injury. For hyperventilation alone, the relative risk (RR) for death or severe disability was 1.14 (95% CI 0.82 to 1.58). The RR for death or severe disability in the hyperventilation plus tromethamine group was 0.87 (95% CI 0.58 to 1.28). The authors conclude that the available data are inadequate to assess potential benefits or harm that might result from hyperventilation in severe head injury.
19. 19 Diringer MN, Yundt K, Videen TO, Adams RE, Zazulia AR, Deibert E, et al.: No reduction in cerebral metabolism as a result of early moderate hyperventilation following severe traumatic brain injury. J Neurosurg 2000, 92:7-13. This is a prospective study of moderate hyperventilation, induced early after traumatic brain injury, and its effect on cerebral metabolism. Nine adults were studied, and the data were compared with 10 age-matched control participants. During hyperventilation, global cerebral blood flow, cerebral blood volume, and cerebral venous oxygen content all decreased; but, the cerebral metabolic rate for oxygen remained unchanged. The authors concluded that early, brief, moderate hyperventilation does not impair global cerebral metabolism in patients with severe traumatic brain injury.
20. 20 Yates D, Farrell B, Teasdale G, Sandercock P, Robert I: Corticosteroids in head injury-the CRASH trial. J Accid Emerg Med 1999, 16:83-84. This is a useful announcement.
21. 21 Alderson P, Roberts I: Corticosteroids for acute traumatic brain injury (Cochrane Review) [computer program]. In The Cochrane Library, Issue 4. Oxford, UK: Update Software; 1999. This is a detailed summary analysis of the 19 randomized controlled trials to date.
22. 22 Tasker RC: Emergency treatment of acute seizures and status epilepticus. Arch Dis Child 1998, 79:78-83.
23. 23 Verity CM, Ross EM, Golding J: Outcome of childhood status epilepticus and lengthy febrile convulsions: findings of national cohort study. BMJ 1993, 307:225-228.
24. 24 Smith RA, Martland T, Lowry MF: Children with seizures presenting to accident and emergency. J Accident Emerg Med 1996, 13:54-58.
25. 25 Garr RE, Appleton RE, Robson WJ, Molyneux EM: Children presenting with convulsions (including status epilepticus) to a paediatric accident and emergency department: an audit of a treatment protocol. Dev Med Child Neurol 1999, 41:44-47. The results of this audit of 81 children presenting with a convulsion to an emergency department suggest that a defined and consistently applied protocol was effective and relatively safe.
26. 26 Freeman JM: Status epilepticus: it's not what we've thought or taught. Pediatrics 1989, 83:444-445.
27. 27 Maytal J, Shinnar S, Moshe SL, Alvarez LA: Low morbidity and mortality of status epilepticus in children. Pediatrics 1989, 83:323-331.
28. 28 Crawford TO, Mitchell WG, Fishman LS, Snodgrass SR: Very-high-dose phenobarbital for refractory status epilepticus in children. Neurology 1988, 38:1035-1040.
29. 29 Tasker RC, Boyd SG, Harden A, Matthew DJ: EEG monitoring of prolonged thiopentone administration for intractable seizures and status epilepticus in infants and young children. Neuropediatrics 1989, 20:147-153.
30. 30 Rivera R, Segnini M, Baltodano A, Perez V: Midazolam in the treatment of status epilepticus in children. Crit Care Med 1993, 21:991-994.
31. 31 Lal Koul R, Raj Aithala G, Chacko A, Joshi R, Seif Elbualy M: Continuous midazolam infusion as treatment of status epilepticus. Arch Dis Child 1997, 76:445-448.
32. 32 Igartua J, Silver P, Maytal J, Sagy M: Midazolam coma for refractory status epilepticus in children. Crit Care Med 1999, 27:1982-1985. This retrospective review of eight consecutively treated patients assessed the value of a midazolam treatment algorithm for refractory status epilepticus. Importantly, midazolam up to 24 mg/kg/min was not associated with cardiovascular instability.
33. 33 Rashkin MC, Youngs C, Penovich P: Pentobarbital treatment of refractory status epilepticus. Neurology 1987, 37:500-503.
34. 34 Van Ness PC: Pentobarbital and EEG burst suppression in treatment of status epilepticus refractory to benzodiazepines and phenytoin. Epilepsia 1990, 31:61-67.
35. 35 Holmes GL, Riviello JJ: Midazolam and pentobarbital for refractory status epilepticus. Pediatr Neurol 1999, 20:259-264.
36. 36 Gilbert DL, Glauser TA: Complications and costs of treatment of refractory generalized convulsive status epilepticus in children. J Child Neurol 1999, 14:597-601. This systematic review of 111 children with refractory status epilepticus indicated that benzodiazepines appear to have higher drug costs but lower complications and overall costs in comparison with barbiturates.
37. 37 Gilbert DL, Gartside PS, Glauser TA: Efficacy and mortality in treatment of refractory generalized convulsive status epilepticus in children: a metaanalysis. J Child Neurol 1999, 14:602-609. This meta-analysis of 111 children treated with diazepam, midazolam, thiopental, pentobarbital, or isoflurane for refractory status epilepticus aimed to determine the effect of drug treatment on seizure control and mortality rate. Overall mortality rate was 20 and 4% in symptomatic and idiopathic children, respectively. Numbers, differing etiologies, and lack of standardized treatment did not permit valid therapeutic comparison.
38. 38 Tasker RC, Matthew DJ, Helms P, Dinwiddie R, Boyd S: Monitoring in nontraumatic coma. Part 1: Invasive intracranial measurements. Arch Dis Child 1988, 63:888-894.
39. 39 Tasker RC, Boyd SG, Harden A, Kendall B, Harding BN, Matthew DJ: The clinical significance of seizures in critically ill young infants requiring intensive care. Neuropediatrics 1991, 22:129-138.
40. 40 Keegan BM, Lowry NJ, Yager JY: Mycoplasma pneumoniae: a cause of coma in the absence of meningoencephalitis. Pediatr Neurol 1999, 21:822-825.
41. 41 Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF: Neurologic complications in children with enterovirus 71 infection. N Engl J Med 1999, 341:936-942. This report of 41 Taiwanese children with culture-confirmed enterovirus 71 infection and acute neurologic manifestations describes three syndromes: aseptic meningitis, brain stem encephalitis, and acute flaccid paralysis. Of these, the chief complication was brain stem encephalitis (or rhomboencephalitis), which had a fatality rate of 14%, with the most common initial symptom of myoclonus.
42. 42 Easley RB, Cooperstock MS, Tobias JD: Cat-scratch disease causing status epilepticus in children. South Med J 1999, 92:73-76. This is a description of two children with status epilepticus secondary to cat-scratch disease.
43. 43 Armengol CE, Hendley JO: Cat-scratch disease encephalopathy: a cause of status epilepticus in school-aged children. J Pediatr 1999, 134:635-638. This is a description of six more children presenting with status epilepticus.
44. 44 Seals JE, Oken HA: Cat scratch encephalopathy. Md Med J 1999, 48:176-178.
45. 45 Thebaud B, Husson B, Navelet Y, Huault G, Landrieu P, Devictor D, et al.: Haemorrhagic shock and encephalopathy syndrome: neurological course and predictors of outcome. Intensive Care Med 1999, 25:293-299. This is a detailed, retrospective description of 14 patients who fulfilled the hemorrhagic shock encephalopathy syndrome criteria. Of note, an 8-year period seasonal clustering in the winter months was observed for this devastating illness.
46. 46 Bacon CJ, Bell SA, Gaventa JM, Greenwood DC: Case control study of thermal environment preceding haemorrhagic shock encephalopathy syndrome. Arch Dis Child 1999, 81:155-158.
47. 47 Meda HA, Diallo B, Buchet JP, Lison D, Barennes H, Ouangre A, et al.: Epidemic of fatal encephalopathy in preschool children in Burkina Faso and consumption of unripe ackee (Blighia sapida) fruit. Lancet 1999, 353:536-540. This is a description of 29 cases of epidemic fatal encephalopathy. Consumption of unripe ackee fruit probably caused this epidemic, in which the most common symptoms were hypotonia, vomiting, convulsions, and coma. All children died within 48 hours.
48. 48 Adverse events associated with ingestion of gamma-butyrolactone-Minnesota, New Mexico, and Texas, 1998-1999. MMWR Morb Mortal Wkly Rep 1999, 48:137-140.
49. 49 Viera AJ, Yates SW: Toxic ingestion of gamma-hydroxybutyric acid. South Med J 1999, 92:404-405. γ-Hydroxybutric acid has become a popular new drug of abuse, and toxicity should be considered in any patient with altered mental state and appropriate history. This report vividly describes a 17-year-old male who became obtunded after drug ingestion.
50. 50 Echenne B, Ducros A, Rivier F, Joutel A, Humbertclaude V, Roubertie A, et al.: Recurrent episodes of coma: an unusual phenotype of familial hemiplegic migraine with linkage to chromosome 1. Neuropediatrics 1999, 30:214-217.